This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Vegenics Pty Limited. Active years: 2011.
Company Filing History:
Years Active: 2011
Title: Marko J T Uutela: Innovator in Angiogenic Research
Introduction
Marko J T Uutela is a prominent inventor based in Helsinki, Finland. He has made significant contributions to the field of angiogenic research, particularly through his innovative work on modified VEGF-A. His research focuses on enhancing the properties of vascular endothelial growth factor, which plays a crucial role in blood vessel formation.
Latest Patents
Uutela holds a patent for a chimeric polypeptide that comprises a VEGFR-2 ligand. This invention, titled "Modified VEGF-A with improved angiogenic properties," outlines methods and compositions for creating and utilizing these chimeric molecules. The chimeric molecules retain VEGFR-2 binding activity and exhibit enhanced angiogenic activity compared to native VEGF-A. He has 1 patent to his name.
Career Highlights
Marko J T Uutela is associated with Vegenics Pty Limited, where he continues to advance his research in the field of biotechnology. His work has implications for therapeutic applications, particularly in conditions where angiogenesis is a critical factor.
Collaborations
Uutela has collaborated with notable researchers in his field, including Kari Alitalo and Tuomas Tammela. These collaborations have further enriched his research and contributed to the advancement of angiogenic therapies.
Conclusion
Marko J T Uutela is a key figure in the field of angiogenic research, with a focus on innovative solutions that enhance vascular growth. His contributions through patents and collaborations continue to impact the scientific community positively.